Covid-19 vaccine for children: Govt panel recommends emergency approval for Serum Institute’s Covovax for 7-11 year olds

Covid-19 vaccine for children: Govt panel recommends emergency approval for Serum Institute’s Covovax for 7-11 year olds

An expert panel of India’s central drug authority on Friday recommended granting emergency use authorisation to Serum Institute’s Covovax for children aged 7 to 11 years, official sources said. The recommendation has been sent to Drugs Controller General of India (DCGI) for final approval. The application for emergency use authorisation was submitted by Prakash Kumar … Read more

Covid-19 vaccine: Covovax gets emergency nod for 12-18 age group

Covid-19 vaccine: Covovax gets emergency nod for 12-18 age group

The Novavax vaccine is manufactured and marketed in India by SII under the brand name, Covovax. The Drugs Controller General of India (DCGI) has granted emergency use authorisation (EUA) for the Novavax and Serum Institute of India (SII) Covid-19 vaccine, Covovax, in the 12-18 age group. Covovax is the fourth vaccine to receive EUA from … Read more

COVID-19 treatment: Roche’s antibody cocktail explained; why it is approved in India

COVID-19 treatment: Roche’s antibody cocktail explained; why it is approved in India

The antibody cocktail is expected to be administered among patients who are at a high risk of developing a severe form of COVID-19 infection. Last week, drug firm Roche India received approvals for the Emergency Use Authorisation (EUA) from the Central Drugs Standards Control Organisation (CDSCO) for the antibody cocktail to be used in treatment … Read more